An artificial neural network to predict the outcome of repeat prostate biopsies

Urology

Volumn 62, Issue 3, 2003, Pages 456-460

  Remzi, Mesut ^a   Anagnostou, Theodore ^b   Ravery, Vincent ^b   Zlotta, Alexandre ^b   Stephan, Carsten ^b   Marberger, Michael ^b   Djavan, Bob ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ALGORITHM; AREA UNDER THE CURVE; ARTICLE; ARTIFICIAL NEURAL NETWORK; CANCER DIAGNOSIS; CANCER PATIENT; CLINICAL EXAMINATION; CONTROLLED STUDY; DATA BASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; EUROPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEEDLE BIOPSY; ORGAN SIZE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CARCINOMA; STATISTICAL SIGNIFICANCE; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT OUTCOME;

EID: 0042734859     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(03)00409-6     Document Type: Article

References (15)

1. Djavan B., Zlotta A.R., Remzi M., et al. Optimal predictors of prostate cancer in repeat prostate biopsy a prospective study in 1051 men . J Urol. 163:2000;1144-1148.
2. Fowler J.E. Jr, Bilgler S.A., Miles D., et al. Predictors of first repeat biopsy cancer detection with suspected local stage prostate cancer. J Urol. 163:2000;813-818.
3. Borboroglu P.G., Comer S.W., Riffenburgh R.H., et al. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. J Urol. 13:2000;158-162.
4. Noguchi M., Yahara J., Koga H., et al. Necessity of repeat biopsies in men for suspected prostate cancer. Int J Urol. 6:1999;7-12.
5. Reckwitz T., Potter S.R., Snow P.B., et al. Artificial neural networks in urology update 2000 . Prostate Cancer Prostatic Dis. 2:1999;222-226.
6. Djavan B., Remzi M., Zlotta A.R., et al. Novel artificial neural network for early detection of prostate cancer. J Clin Oncol. 20:2002;921-929.
7. Finne P., Finne R., Auvinen A., et al. Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron network. Urology. 56:2000;418-422.
8. Horninger W., Bartsch G., Snow P.B., et al. The problem of cutoff levels in a screened population. Cancer. 91:2001;1667-1672.
9. Babaian R.J., Fritsche H., Ayala A., et al. Performance of neural network in detecting prostate cancer in the prostate specific antigen reflex range of 2.5 to 4.0 ng/mL. Urology. 56:2000;1000-1006.
10. Remzi M., Djavan B., Wammack R., et al. Can total and transition zone volume of the prostate decide whether to perform a repeat biopsy? Urology. 61:2003;161-166.
11. Catalona W.J., Partin A.W., Slawin K.M., et al. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease a prospective multicenter clinical trial . JAMA. 279:1998;1542-1547.
12. Hodge K.K., McNeal J.E., Terris M.K., et al. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol. 142:1989;71-74.
13. Stephan C., Jung K., Cammann H., et al. An artificial neural network considerably improves the diagnostic power of percent free prostate-specific antigen in prostate cancer diagnosis results of a 5-year investigation . In J Cancer. 99:2002;466-473.
14. Stephan C., Cammann H., Semjonow A., et al. Multicenter evaluation of an artificial neural network to increase prostate cancer detection rate and reduce unnecessary biopsies. Clin Chem. 48:2002;1279-1287.
15. Djavan B., Remzi M., Schulman C.C., et al. Repeat prostate biopsy who, how and when? A review . Eur Urol. 42:2002;93-103.